ERIC joined with other business groups in a letter sent to the U.S. Senate today sharing support for, and feedback on, the Patient-Centered Outcomes Research Institute Reauthorization Act discussion draft.
The letter reads, ” We believe comparative effectiveness research (CER) is important, and the Patient-Centered Outcomes Research Institute (PCORI) serves as a trustworthy source of CER. PCORI fills gaps in existing healthcare research by including the patient perspective every step of the way.” It also thanks Senators for addressing a number of key concerns regarding current limitations on PCORI’s ability to fulfill this mission.
Additionally, the letter addresses several technical challenges with the funding for PCORI and requests the changes to the authorizing language:
· Prevent Double Counting for Assessment Purposes
· PCORI Fee Waiver for Plan Year 2020
· Changes to Stakeholder Representatives
Click here to read the letter in its entirety.